AMOYTOP(SH:688278) Zheng Quan Zhi Xing·2025-09-05 11:24Core Viewpoint - The company, Amoytop Biopharmaceuticals Co., Ltd., is holding a performance briefing on September 15, 2025, to discuss its 2025 semi-annual financial results and operational performance with investors [1][2]. Group 1: Meeting Details - The performance briefing is scheduled for September 15, 2025, from 15:00 to 17:00 [2][3]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [2][3]. - Investors can submit questions from September 8 to September 12, 2025, through the Roadshow Center website or via the company's email [3]. Group 2: Participants - Key participants in the meeting will include the company's Chairman and General Manager, Mr. Sun Li, and the Vice General Manager and Financial Director, Ms. Yang Yiling, along with independent director Mr. Liu Qi [2]. Group 3: Investor Participation - Investors can participate in the performance briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date and time [2][3]. - The company will address commonly asked questions during the briefing [2][3]. Group 4: Contact Information - For inquiries, investors can contact the Board Office at phone number 0592-6889118 or via email at ir@amoytop.com [3].